Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
Bioxytran (BIXT) Stock Price & Analysis
11 Followers
BIXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.15 - $1.25
Previous Close$0.32
Volume36.69K
Average Volume (3M)82.48K
Market Cap
$41.41M
Enterprise Value$42.80M
Total Cash (Recent Filing)$153.80K
Total Debt (Recent Filing)$2.17M
Price to Earnings (P/E)-16.3
Beta52.87
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding130,595,578
10 Day Avg. Volume31,547
30 Day Avg. Volume82,479
Standard Deviation2.73
R-Squared0.00005
Alpha0.66
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-19.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bioxytran News
Press ReleasesBioxytran Interview at the Emerging Growth Conference
Press ReleasesBioxytran Interview at the Emerging Growth Conference
Press ReleasesBioxytran Interview at the Emerging Growth Conference
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BIXT FAQ
What was Bioxytran Inc’s price range in the past 12 months?
Bioxytran Inc lowest stock price was $0.15 and its highest was $1.25 in the past 12 months.
What is Bioxytran Inc’s market cap?
Currently, no data Available
When is Bioxytran Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioxytran Inc’s earnings last quarter?
Currently, no data Available
Is Bioxytran Inc overvalued?
According to Wall Street analysts Bioxytran Inc’s price is currently Overvalued.
Does Bioxytran Inc pay dividends?
Bioxytran Inc does not currently pay dividends.
What is Bioxytran Inc’s EPS estimate?
Bioxytran Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxytran Inc have?
Bioxytran Inc has 130,595,580 shares outstanding.
What happened to Bioxytran Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bioxytran Inc?
Currently, no hedge funds are holding shares in BIXT
---
Bioxytran Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
60.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-71.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bioxytran Inc
BioXyTran, Inc. is a pharmaceutical company, which engages in the development, manufacturing and commercialization of first-in-class treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. Its products include BXT-25, an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked. The company was founded on October 5, 2017 and is headquartered in Newton, MA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Agile Therapeutics
―
Bio-Path Holdings
―
Clearside Biomedical
―
Galectin Therapeutics
―
---